Biomedical Magnetic Resonance Research Group (REMA), Louvain Drug Research Institute (LDRI), UCLouvain, Brussels, Belgium.
Nuclear and Electron Spin Technologies Platform (NEST), Louvain Drug Research Institute (LDRI), UCLouvain, Brussels, Belgium.
Free Radic Biol Med. 2024 Mar;213:11-18. doi: 10.1016/j.freeradbiomed.2024.01.012. Epub 2024 Jan 11.
The monitoring of acidosis and hypoxia is crucial because both factors promote cancer progression and impact the efficacy of anti-cancer treatments. A phosphonated tetrathiatriarylmethyl (pTAM) has been previously described to monitor both parameters simultaneously, but the sensitivity to tackle subtle changes in oxygenation was limited. Here, we describe an innovative approach combining the pTAM radical and lithium phthalocyanine (LiPc) crystals to provide sensitive simultaneous measurements of extracellular pH (pH) and pO. Both parameters can be measured simultaneously as both EPR spectra do not overlap, with a gain in sensitivity to pO variations by a factor of 10. This procedure was applied to characterize the impact of carbogen breathing in a breast cancer 4T1 model as a proof-of-concept. No significant change in pH and pO was observed using pTAM alone, while LiPc detected a significant increase in tumor oxygenation. Interestingly, we observed that pTAM systematically overestimated the pO compared to LiPc. In addition, we analyzed the impact of an inhibitor (UK-5099) of the mitochondrial pyruvate carrier (MPC) on the tumor microenvironment. In vitro, the exposure of 4T1 cells to UK-5099 for 24 h induced a decrease in pH and oxygen consumption rate (OCR). In vivo, a significant decrease in tumor pH was observed in UK-5099-treated mice, while there was no change for mice treated with the vehicle. Despite the change observed in OCR, no significant change in tumor oxygenation was observed after the UK-5099 treatment. This approach is promising for assessing in vivo the effect of treatments targeting tumor metabolism.
酸血症和缺氧的监测至关重要,因为这两个因素都促进癌症的进展,并影响抗癌治疗的效果。先前已经描述了一种膦化四噻吩三芳基甲烷(pTAM),可以同时监测这两个参数,但对氧合细微变化的敏感性有限。在这里,我们描述了一种创新的方法,将 pTAM 自由基和锂酞菁(LiPc)晶体结合在一起,提供对细胞外 pH(pH)和 pO 的敏感的同时测量。由于两个 EPR 光谱不重叠,因此可以同时测量这两个参数,并且对 pO 变化的敏感性提高了 10 倍。该程序应用于乳腺癌 4T1 模型中研究了碳化氧合作用的影响,作为概念验证。单独使用 pTAM 时,pH 和 pO 没有明显变化,而 LiPc 检测到肿瘤氧合作用明显增加。有趣的是,我们观察到 pTAM 系统地高估了 pO 与 LiPc 的比值。此外,我们分析了线粒体丙酮酸载体(MPC)抑制剂(UK-5099)对肿瘤微环境的影响。在体外,将 4T1 细胞暴露于 UK-5099 24 小时会导致 pH 和耗氧量(OCR)降低。在体内,用 UK-5099 治疗的小鼠中观察到肿瘤 pH 值显著降低,而用载体治疗的小鼠则没有变化。尽管观察到 OCR 发生变化,但 UK-5099 治疗后肿瘤氧合没有明显变化。这种方法有望用于评估治疗肿瘤代谢的治疗方法的体内效果。